Christopher Wraight
Vorstandsvorsitzender bei MecRx Pty Ltd.
Aktive Positionen von Christopher Wraight
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
MecRx Pty Ltd.
 MecRx Pty Ltd. Pharmaceuticals: MajorHealth Technology MecRx Pty Ltd. develops drugs for treatment of cancer. The company was founded by Ian Holmes, Jo Alcindor, Tom Peat and Janet Newman in 2013 and is headquartered in Melbourne, Australia. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Christopher Wraight
Ehemalige bekannte Positionen von Christopher Wraight
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 06.11.2009 | 31.08.2010 |
Otifex Therapeutics Pty Ltd.
 Otifex Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Otifex Therapeutics Pty Ltd. develops treatment for ear diseases. The company was founded by Burkhard Franz and Colin Anderson in 2009 and is headquartered in Melbourne, Australia. | Vorstandsvorsitzender | 25.11.2013 | - |
| Geschäftsführer | 01.01.2011 | 25.11.2013 |
Ausbildung von Christopher Wraight
| LaTrobe University | Doctorate Degree |
| Chifley Business School | Masters Business Admin |
Statistik
International
| Australien | 6 |
Operativ
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Chief Operating Officer | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PERCHERON THERAPEUTICS LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Otifex Therapeutics Pty Ltd.
Otifex Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Otifex Therapeutics Pty Ltd. develops treatment for ear diseases. The company was founded by Burkhard Franz and Colin Anderson in 2009 and is headquartered in Melbourne, Australia. | Health Technology |
MecRx Pty Ltd.
MecRx Pty Ltd. Pharmaceuticals: MajorHealth Technology MecRx Pty Ltd. develops drugs for treatment of cancer. The company was founded by Ian Holmes, Jo Alcindor, Tom Peat and Janet Newman in 2013 and is headquartered in Melbourne, Australia. | Health Technology |
- Börse
- Insiders
- Christopher Wraight
- Erfahrung
